Telephone: 212.931.0704

In re Aggrenox Antitrust Litigation, 3:14-md-2516-SRU (D. Conn.)

We represent plaintiffs and direct purchasers of Aggrenox in this class action alleging that brand and generic drug companies entered into an unlawful agreement to prevent the entry of generic competition in the market for capsules of 200 mg extended releasedipyridamole and 25 mg acetylsalicylic acid, sold under the brand name Aggrenox.  We seek to recover overcharges on behalf of the class of direct purchasers under the federal antitrust laws.  Plaintiffs prevailed against the drug manufacturers’ motion to dismiss the case, and are proceeding to discovery.

Reach Out

Taus, Cebulash & Landau, LLP • 80 Maiden Lane • Suite 1204 • New York, NY 10038 • T: 212.931.0704 • E: